Bristol-myers squibb, revlimid 20MG cap
Ended Awarded Last action
- Contract number
- 15B50526F00000153
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Federal Medical Center Carswell
Correctional Facilities, Department of Justice
- Obligated
- $11,319
Award facts
- Contract value 100% obligated
- $11,319.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Princeton, NJ 08543, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company received a delivery order valued at $11.3 million from the Department of Veterans Affairs for the supply of REVLIMID (lenalidomide) 20mg capsules to Federal Medical Center Carswell. The order was awarded on March 1, 2026, with a completion date of March 31, 2026, under a firm fixed-price contract with no set-aside designation. This delivery order is issued under Bristol-Myers Squibb's Federal Supply Schedule contract (36F79724D0101) for Pharmaceuticals and Drugs (FSS-61-IB), a multiple-award indefinite delivery/indefinite quantity agreement with a ceiling value of $12.3 billion extending through April 30, 2029. The pharmaceutical will be supplied from the company's Lawrenceville, New Jersey facility to support the VA's oncology treatment capabilities.
REVLIMID is a specialized immunomodulatory agent used in the treatment of multiple myeloma and other hematologic malignancies, representing part of Bristol-Myers Squibb's broader portfolio of advanced cancer therapies supplied to the Veterans Health Administration. Bristol-Myers Squibb has established itself as a critical supplier to the VA through its Federal Supply Schedule vehicle, having issued more than fifty documented delivery orders since 2022 across multiple Veterans Integrated Service Networks. The company's federal contracting activity demonstrates sustained demand for its specialized oncology and cell therapy products, reflecting the VA's commitment to providing eligible veterans access to current standard-of-care cancer treatments and advanced immunotherapy options.
Quick answers
Who was awarded contract 15B50526F00000153?
15B50526F00000153 was awarded to Bristol-Myers Squibb Company by Federal Medical Center Carswell (Correctional Facilities) on March 1, 2026.
How much is contract 15B50526F00000153 worth?
The government has obligated $11,319 on 15B50526F00000153.
Is contract 15B50526F00000153 an order under another contract?
Yes. 15B50526F00000153 is a delivery order under 36F79724D0101, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50526F00000153 competed?
The extent of competition for 15B50526F00000153 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award